B.C. Health Minister Adrian Dix speaks during a health-care funding announcement, in Vancouver on February 12, 2024. PHOTO BY DARRYL DYCK /THE CANADIAN PRESS
Chimeric antigen receptor T-cell Therapy (CAR-T) collects a patient’s white blood cells and genetically engineers them to kill cancer cells
B.C. is beginning to offer an immunotherapy cancer treatment in the province for some patients who haven’t had success with standard chemotherapy or radiation.
Chimeric antigen receptor T-cell Therapy, commonly referred to as CAR-T, treats lymphoma and leukemia by collecting a patient’s white blood cells and genetically engineering them to recognize and kill cancer cells.
- Man says his rights violated by B.C.’s demand he explain source of money to buy house
- More pay parking at Metro Vancouver parks angers hikers, day-trippers
- Ryan Reynolds’ company teams up with casket maker to kill daylight saving time
- $600 a night? Summer hotel prices could rise when B.C.’s short-term rental rules begin
- New survey reveals the stark reality for B.C’s nonbinary youth. Politics is making it worse
Dr. Kim Chi, the chief medical officer for BC Cancer, says patients who needed the treatment would previously have to be sent outside the province or country.
Provincial Health Minister Adrian Dix says $14.3 million in this year’s budget means up to 20 adults and five children will be able to get treatment at Vancouver General Hospital or BC Children’s Hospital starting this month.
Chi says the therapy is an example of how far cancer treatments have evolved, driven by “cutting edge” research and technology.
MJ Asrat, whose son Hugo received CAR-T therapy as part of a clinical trial, told the press conference announcing the funding that it made him healthy enough to receive a bone-marrow transplant after more than three and a half years of chemotherapy to treat his leukemia.
